Shire pays US authorities $350m to settle illegal kickbacks case

Follow the author of this article

Follow the topics within this article

Pharmaceuticals giant Shire is to pay $350m ($287m) to settle a lawsuit with the US Department of Justic (DoJ) in which it was claimed that the rare disease specialist used illegal kickbacks, such as lavish dinners and cash, to encourage doctors and clinics to buy its products.

The settlement relates to Advanced BioHealing, a company that Dublin-domiciled Shire acquired in 2011 and sold in 2014, and its product Dermagraft, a human skin substitute used to treat diabetic foot ulcers.